Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology PDC In Vitro High-Throughput Pharmacodynamic Evaluation Platform

Author:

InnoModels

Release time:

2024-09-04

In the vast field of life sciences and drug discovery, innovation is an important driving force for progress. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. has provided unprecedented accuracy and reliability for new drug discovery and development with its PDC (Patient-derived tumor cell) in vitro high-throughput drug efficacy evaluation platform. In this paper, we will discuss the technical advantages, application areas and significance of this innovative platform for drug discovery and development.
Technical Background and Advantages
PDC model is a new generation of tumor model established by short-term culture of surgically resected patient's tumor tissue, or tumor cells obtained from PDX (Patient-Derived Xenograft) model or 3D organoid model that has already been modeled, in an in vitro culture system. This model not only retains the genetic characteristics of the primary tumor, but also maintains the heterogeneity of the patient's tumor, making its pharmacodynamic results highly relevant to the clinic. The PDC in vitro high-throughput pharmacodynamic evaluation platform of InnoModels Biotechnology is based on this model, and through cutting-edge technology, it obtains primary cells highly consistent with patients from the digested products of the PDX model, which provides highly accurate pharmacodynamic evaluations for drug discovery and clinical treatment.
The core strength of the platform is its ability for high-throughput, multi-parameter evaluation. Researchers can simultaneously assess multiple cell phenotypic parameters, such as cell proliferation, cell cycle, and apoptosis, to provide a more comprehensive understanding of drug effects. In addition, PDC technology supports the application of multiple cell types, including tumor cells, primary cells, etc., which is suitable for drug research in different disease areas. This comprehensive approach to cell phenotype assessment makes it possible to establish more complex disease models, which helps to study in depth the effects of drugs in complex disease environments.

Application Fields and Achievements
InnoModels' PDC in vitro high-throughput drug efficacy evaluation platform has achieved remarkable results in a number of fields. First, in the development and discovery of anti-cancer drugs, the platform accelerates the screening and development process of anti-cancer drugs through the multi-parameter evaluation of tumor cells. Researchers are able to find potential drug candidates more quickly and accurately, bringing hope to tumor patients.
Second, the platform also plays an important role in neurological disease and infectious disease research. By modeling complex neurological diseases, researchers can better understand the effects of drugs in the nervous system and provide new ideas for the treatment of neurodegenerative diseases. Meanwhile, for infectious disease research, the PDC platform provides an efficient and comprehensive in vitro research platform to accelerate the discovery of antiviral drugs.
Clinical value and social significance
In addition to drug screening and R&D, InnoModels' PDC in vitro high-throughput drug efficacy evaluation platform also has important clinical value. By comparing the subject drug with counterpart drugs (e.g., drugs with similar mechanism of action or standardized therapeutic drugs), the platform can predict the clinical efficacy of a drug, providing strong support for the clinical application of the drug. In addition, by comparing the effective rates of different cancer type models, the indications of the drugs can be determined, providing a scientific basis for the clinical use of drugs.
More importantly, the platform is able to search for biomarkers that can predict drug efficacy by analyzing the difference in genetic characteristics between sensitive and resistant models. The discovery of these biomarkers not only helps to optimize drug treatment protocols and improve therapeutic efficacy, but also provides an important reference for individualized medicine and promotes the personalized development of the medical industry.
Conclusion
The emergence of the InnoModels Biotechnology PDC in vitro high-throughput drug efficacy evaluation platform has brought unprecedented accuracy and reliability to drug development and clinical treatment. With its unique technological advantages and wide range of applications, the platform is leading a new era of drug development. We expect that InnoModels Biotechnology will continue to play a leading role in the field of life sciences in the future and make greater contributions to human health.

Introducing the latest features of InnoModels Biotechnology IC50 platform

InnoModels Biotechnology iHuPDX Platform

Introducing the latest features of InnoModels Biotechnology IC50 platform

InnoModels Biotechnology iHuPDX Platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License